XENE – xenon pharmaceuticals inc. - common shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

XENE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/10

09:04 am

xene

Rating for XENE

Low Report

Rating for XENE

Report

3/10

09:04 am

xene

Rating for XENE

Low Report

Rating for XENE

Report

3/10

08:25 am

xene

Rating for XENE

Low Report

Rating for XENE

Report

3/10

08:25 am

xene

Rating for XENE

Low Report

Rating for XENE

Report

3/10

07:52 am

xene

Rating for XENE

Medium Report

Rating for XENE

Report

3/10

07:52 am

xene

Rating for XENE

Medium Report

Rating for XENE

Report

3/9

04:05 pm

xene

Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Guggenheim.

Low Report

Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Guggenheim.

Report

3/9

04:05 pm

xene

Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Guggenheim.

Low Report

Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Guggenheim.

Report

3/9

01:44 pm

xene

Rating for XENE

Low Report

Rating for XENE

Report

3/9

01:44 pm

xene

Rating for XENE

Low Report

Rating for XENE

Report

3/9

01:16 pm

xene

Rating for XENE

Low Report

Rating for XENE

Report

3/9

01:16 pm

xene

Rating for XENE

Low Report

Rating for XENE

Report

3/9

11:05 am

xene

Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Bank of America Corporation.

Low Report

Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Bank of America Corporation.

Report

2/27

02:12 pm

xene

Rating for XENE

Low Report

Rating for XENE

Report

2/27

02:12 pm

xene

Rating for XENE

Low Report

Rating for XENE

Report

2/27

11:28 am

xene

Rating for XENE

Low Report

Rating for XENE

Report

2/27

11:28 am

xene

Rating for XENE

Low Report

Rating for XENE

Report

2/25

06:24 am

xene

Xenon Pharmaceuticals (XENE) was upgraded by Wolfe Research to "strong-buy".

Low Report

Xenon Pharmaceuticals (XENE) was upgraded by Wolfe Research to "strong-buy".

Report

2/25

06:24 am

xene

Xenon Pharmaceuticals (XENE) was upgraded by Wolfe Research to "strong-buy".

Low Report

Xenon Pharmaceuticals (XENE) was upgraded by Wolfe Research to "strong-buy".

Report

2/24

07:23 am

xene

Rating for XENE

Medium Report

Rating for XENE

Report

2/24

07:23 am

xene

Rating for XENE

Medium Report

Rating for XENE

Report

2/23

06:01 pm

xene

Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.

Low Report

Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.

Report

2/23

06:01 pm

xene

Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.

Low Report

Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.

Report

2/23

04:10 pm

xene

Xenon Pharmaceuticals initiated with an Outperform at Wolfe Research

Medium Report

Xenon Pharmaceuticals initiated with an Outperform at Wolfe Research

Report

2/23

04:10 pm

xene

Xenon Pharmaceuticals initiated with an Outperform at Wolfe Research

Medium Report

Xenon Pharmaceuticals initiated with an Outperform at Wolfe Research

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.